Supplemental methods ("Guselkumab and risankizumab for psoriasis: a 44-week indirect real life comparison ")
Published: 12 January 2021| Version 1 | DOI: 10.17632/9by92fmdsx.1
Contributors:
Angelo Ruggiero, Gabriella Fabrocini, Eleonora Cinelli, Matteo MegnaDescription
Supplemental methods
Files
Institutions
- Azienda Ospedaliera Universitaria Federico II
Categories
Dermatology